Hansa Biopharma to Present at Healthcare Conference

Hansa Biopharma AB announced on August 27 that its CEO, Renée Aguiar-Lucander, will participate in Pareto Securities' 17th Annual Healthcare Conference in Stockholm. Aguiar-Lucander is slated to give a presentation on September 2, from 12:45 to 13:05 CEST.

The CEO will also join a panel discussion later the same day, from 14:50 to 15:10 CEST. The conference provides a platform for companies in the healthcare sector to discuss industry trends and strategies.

This event offers investors and industry professionals a chance to hear directly from company leadership about their outlook and plans. Hansa Biopharma focuses on developing treatments for rare diseases.

Interested parties seeking to meet with Hansa Biopharma's management can contact the company's investor relations department.